Thea Pharma

Thea Pharma's product portfolio consists of seven major ophthalmic products regulated or approved by the U.S. Food and Drug Administration (FDA), including Zioptan®, AcellFX™, Cosopt®, Cosopt™ PF, Azasite®, Akten®, Betimol®, iVIZIA dry eye drops and eyelid hygiene products, as well as IYUZEH™. By focusing our passion and expertise on the U.S. market, Thea Pharma aims to deliver uncompromising care, enabling all stakeholders to look ahead with wide-open eyes to the future of ophthalmic treatments.